FTC seeks public comment on Cardinal Health nuclear pharmacy sales to Patient Care Infusion

The FTC is seeking public comment on Cardinal Health’s application to sell its former nuclear pharmacy assets to Patient Care Infusion. Cardinal is required to sell these assets–located in Las Vegas, Albuquerque, and El Paso–under the 2011 settlement with the FTC for its acquisition of three nuclear pharmacies from Biotech.

Public comments on the sale will be accepted until March 26, 2012.

Source: FTC Press Release


Related ContentReviving Competition in Healthcare Markets: The Use of Section 5 of the FTC Act (David Balto)


More Articles